Research ArticleOpen AccessGoogle Scholar indexed
A microliter incubator array for understanding culture condition selectivity
Department of Mechanical and Materials Engineering, University of Denver, Denver, USA
Department of Biological Sciences, University of Denver, Denver, USA
Department Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, USA
Department of Mechanical and Materials Engineering, University of Denver, Denver, USA
- 1 Department of Mechanical and Materials Engineering, University of Denver, Denver, USA
- 2 Department of Biological Sciences, University of Denver, Denver, USA
- 3 Department Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, USA
- 4 Department of Mechanical and Materials Engineering, University of Denver, Denver, USA
Advances in Bioscience and Biotechnology·Volume 03 (2012)·Pages 87–91·Published 13 February 2012·DOI10.4236/abb.2012.31013
Copy link · social · email
Abstract
The emergence of antibiotic-resistant bacterial strains and the weaponization of rare bacterial strains pose a potential threat of pandemic disease. Those involved in the treatment and control of infectious diseases have called for the development of a device capable of rapidly, simultaneously, and safely investigate a myriad of culture conditions. In response to this need, a microliter incubator array system is described and results from a proof-of-concept study using yeast cells to determine optimal growth conditions is presented.
KeywordsMicrofluidicsInfectious DiseasesIncubation
- Lederberg, J. (2000) Infectious history. Science, 288, 287-293. doi:10.1126/science.288.5464.287
- Hammerschmidt, S., Hacker, J. and Klenk, H.-D. (2005) Threat of infection: Microbes of high pathogenic potential—Strategies for detection, control and eradication. International Journal of Medical Microbiology, 295, 141- 151. doi:10.1016/j.ijmm.2005.03.004
- Fauci, A.S. (2006) Emerging and re-emerging infectious diseases: Influenza as a prototype of the host-pathogen balancing act. Cell, 124, 665-670. doi:10.1016/j.cell.2006.02.010
- Rino, R. (2001) Reverse vaccinology, a genome-based approach to vaccine development. Vaccine, 19, 2688- 2691. doi:10.1016/S0264-410X(00)00554-5
- Raoult, D., et al. (2000) Cultivation of the bacillus of Whipple’s Disease. New England Journal of Medicine, 342, 620-625. doi:10.1056/NEJM200003023420903
- Mora, M., et al. (2003) Reverse vaccinology. Drug Discovery Today, 8, 459-464. doi:10.1016/S1359-6446(03)02689-8
- M?kel?, P.H. (2000) Vaccines, coming of age after 200 years. FEMS Microbiology Reviews, 24, 9-20.
- Rappuoli, R. and Covacci, A. (2003) Reverse vaccinology and genomics. Science, 302, 602. doi:10.1126/science.1092329
- Baron, M.D., et al. (2005) The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes. Journal of General Virology, 86, 1093-1101. doi:10.1099/vir.0.80751-0
- Roop, R.M. (1999) Identification of secondary mutations which enhance and stabilize the attenuation of brucella HTRA Mutants: Improving brucella HTRA-based strains as vaccine. University Medical Center, Louisiana State University, Shreveport.
- Cookson, S., et al. (2005) Monitoring dynamics of single-cell gene expression over multiple cell cycles. Molecular Systems Biology, 1, 1-6. doi:10.1038/msb4100032
- Groisman, A., et al. (2005) A microfluidic chemostat for experiments with bacterial and yeast cells. Nature Methods, 2, 685-689. doi:10.1038/nmeth784
- Sparvero, L.J., et al. (2007) Proteomic analysis of the amyloid precursor protein fragment C99: Expression in yeast. Analytical Biochemistry, 370, 162-170. doi:10.1016/j.ab.2007.07.033